Background: Recently, usefulness of intraaortic balloon pump (IABP) for patients with acute myocardial infarction (AMI) and cardiogenic shock (CS) is questioned. Therefore we analysed influence of IABP in CS AMI patients with unsuccessful and successful primary PCI on 30-day mortality. Methods: We analysed 4211 patients with CS and AMI from nationwide PL-ACS registry. Unsuccessful PCI was defined as final TIMI flow grade 0 or 1. Results: Patients with unsuccessful PCI comprised 13.5% (table). In both unsuccessful and successful PCI groups 20% of patients had IABP support and these patients were of the higher risk profile. IABP was associated with lower 30-day mortality in unsuccessful PCI group while with higher in successful PCI group. After adjustment in multivariate Cox proportional model regression IABP remained significantly associated with reduction of 30-day mortality in patients with unsuccessful PCI (HR ¼ 0.71, 95%CI ¼ 0.55-0.91, p¼0.0065) and increased mortality in patients with successful PCI (HR ¼ 1.26, 95%CI ¼ 1.13-1.43, p<0.0001).
Background: The burden of cardiovascular disease is higher amongst Octogenarians (OG). Increasing numbers of OGs are undergoing Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI) against a background of potential excess risks associated with the procedure. There is very limited long-term outcome data available in this patient population.
Methods: Objective: To analyze one year all-cause mortality in OGs who were admitted with a STEMI and received PPCI in a tertiary cardiac centre in the UK and to observe the impact of vascular access (Femoral vs. Radial) on mortality. Design: The registry records of 2951 consecutive STEMI patients, age >50 years admitted between 2005-2011 were reviewed at patient-level data. One year all-cause mortality data was obtained from the national MINAP-UK data base and collated with local registry information. Kaplan-Meier and Cox regression analysis were used to compare mortality between OG and age-group 50-79 years. Results: Of the total population, 8.1 % (n¼241, Mean age:85.3yrs (SD:3.4) were OG of whom 53.5% were male. Use of heparin, warfarin, bivalirudin, aspirin, and clopidogrel were comparable between groups. Use of femoral arterial access (63%) was significantly higher amongst OG (P¼0.04) compared to radial route. In univariate analysis, event-free-survival (hazard ratio: 2.5 CI [1-6.1]) was significantly lower in OG compared to other age group (log rank test, P¼0.001). All-cause mortality was significantly higher amongst OG who had femoral arterial access compared to radial route (log rank test, P¼0.03), but this was not apparent amongst 50-79 age group (log rank, P¼0.06). In Cox regression analysis, after adjusting for gender, conventional risk factors, anticoagulation and antiplatelet-use, femoral access remained significantly associated with one year all cause mortality (hazard ratio:2.8[1-7.3], P¼0.04). Conclusions: OG who received PPCI for STEMI have disproportionately higher one year all cause mortality compared to younger age group. Use of femoral arterial access appears to be independently associated with this excess mortality. Radial access preferred to be the safer option in this high risk population, to improve long term prognosis.
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Use of drug-eluting stent (DES) with bioresorbable polymer in patients with STsegment elevation myocardial infarction (STEMI) -Mid-and long-term clinical outcomes Background: New-generation DES showed favourable outcomes in patients with STEMI. We aim to assess mid-and long-term outcomes in STEMI patients treated with Nobori, DES with bioresorbable polymer. Methods: In 2 large, prospective, multi-center registries, out of 14134 enrolled patients, 1302 patients with STEMI were treated with the Nobori DES. Mid-term and long-term outcomes (up to 1 and 3 years) are available for 806 and 248 patients respectively. Adverse events were adjudicated by CEC.
Results: STEMI patients were 60AE13y old, 79% males, 16% with prior MI and 10% with prior coronary revascularizations. The pain-to-balloon time was <3 hours in 37.6%; >3 < 6 hours in 22.6%; > 6 < 12 hours in 12.8% and > 12 hours in 19.6% of the patients. The median door-to-balloon time was 55 minutes. Lesions were complex (61.9% B2/C), calcified (25.5%), and containing thrombus (47.4%). Low perfusion (TIMI 0/1) was observed in 43.8% of lesions before procedure, while after procedure TIMI 3 was achieved in 96.0%. Most of the STEMIs had anterior (50%) or inferior (39%) location. 43% of all STEMI patients received adjunctive treatment: either hemodynamic support (9.0%), intravenous thrombolysis (15.7%), pre-procedural GP IIB/IIIa inhibitor (9.9%), thrombus aspiration (26.1%) or other specific treatment (14.9%). At 1 year, 8 patients died because of cardiac reasons (1.0%), 15 patients suffered re-infarctions (1.9%) 19 patients underwent TLR (2.4%) and 9 (1.1%) patients TVR. The TLF rate was 3.4%, while MACE rate was 4.3%. There were 9 (1.1%) definite or probable stent thromboses, of which 1 acute, 7 subacute and one late ST. In the patient cohort followed at 3-year, 2 patients died from cardiac causes (0.8%), 10 had re-infarction (4.0%) with a TLF rate of 6.1%. No patient suffered very late stent thrombosis between 1-and 3-years follow-up. Conclusions: Despite limitations of registry and potential bias in enrolling lower risk patients our data show that treatment of STEMI patients with bioresorbable polymer coated DES was associated with favorable mid-and long-term outcomes and low rate of stent thrombosis. Those data, confirm both efficacy and safety of DES with bioresorbable polymer in this complex patient's subset.
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Effects Results: A total of 87 patients were included, mean age was 65AE12 years. Indications for the STENTYS stent were; aneurysm: 25(29%), ectasia: 21(24%), tapering: 27(31%), bifurcation: 22(25%), and SVG: 9(10%). In some target vessels !2 indications applied. Angiographic and procedural success was achieved in 92% and 91% respectively. In 6(8%) patients there was !5% residual stenosis on visual estimate, which might improve over time due to the stents self-apposing properties, 1 patient suffered from an in-hospital MI. No peri-procedural complications occurred. Conclusions: Early angiographic and procedural success of treatment with the STENTYS stent, in patients other than STEMI, are favourable. This single-center experience provides novel insights of angiographic and procedural outcome in complex lesions with a high risk of diameter mismatch. Long-term clinical follow-up, which will be available at TCT, is needed to evaluate whether the self-apposing stent technique translates into favourable clinical outcomes.
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Comparison of long-term outcome between transradial approach and transfemoral approach for patients with ST-segment elevation myocardial infarction.
